Tirzepatide sodium

Tirzepatide is a dual GLP-1R and GPR119 agonist, demonstrating potent in vitro cAMP production and receptor internalization. In vivo, it effectively reduces metabolic parameters in obese mice and shows therapeutic potential in models of type 2 diabetes and associated asthma, highlighting its utility for metabolic and inflammatory disease research.